Artículos de revistas sobre el tema "DAC Report"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "DAC Report".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Rodriguez, María Victoria, Estefanía Butassi, Matías Funes y Susana A. Zacchino. "Synergism between Terbinafine and a Neo-clerodane Dimer or a Monomer Isolated from Baccharis flabellata against Trichophyton rubrum". Natural Product Communications 14, n.º 1 (enero de 2019): 1934578X1901400. http://dx.doi.org/10.1177/1934578x1901400101.
Texto completoObermeier, Fred W. "A report on DAC-87". ACM SIGDA Newsletter 17, n.º 3 (septiembre de 1987): 39. http://dx.doi.org/10.1145/378916.378944.
Texto completoSaba, Hussain, Craig Rosenfeld, Jean-Pierre Issa, John DiPersio, Azra Raza, Virginia Klimek, James Slack, Carlos de Castro, Karl Mettinger y Hagop Kantarjian. "First Report of the Phase III North American Trial of Decitabine in Advanced Myelodysplastic Syndrome (MDS)." Blood 104, n.º 11 (16 de noviembre de 2004): 67. http://dx.doi.org/10.1182/blood.v104.11.67.67.
Texto completoKashimura, Hiroshi, Takashi Inoue, Kuniaki Ogasawara y Akira Ogawa. "Preoperative Evaluation of Neural Tracts by Use of Three-dimensional Anisotropy Contrast Imaging in a Patient with Brainstem Cavernous Angioma: Technical Case Report". Neurosurgery 52, n.º 5 (1 de mayo de 2003): 1226–30. http://dx.doi.org/10.1093/neurosurgery/52.5.1226.
Texto completoShizu, Katsuyuki, Jiyoung Lee, Hiroyuki Tanaka, Hiroko Nomura, Takuma Yasuda, Hironori Kaji y Chihaya Adachi. "Highly efficient electroluminescence from purely organic donor–acceptor systems". Pure and Applied Chemistry 87, n.º 7 (1 de julio de 2015): 627–38. http://dx.doi.org/10.1515/pac-2015-0301.
Texto completoLong, Huei, Chi-Tan Hu y Ching-Feng Weng. "Antrodia Cinnamomea Prolongs Survival in a Patient with Small Cell Lung Cancer". Medicina 55, n.º 10 (26 de septiembre de 2019): 640. http://dx.doi.org/10.3390/medicina55100640.
Texto completoFoster, Harry, Rob Oshana, Jorg Henkel y Vivek De. "Report on the Design Automation Conference (DAC 2021)". IEEE Design & Test 39, n.º 1 (febrero de 2022): 97–99. http://dx.doi.org/10.1109/mdat.2021.3138609.
Texto completoChen, Ping, William Blum, Josephine Aimiuwu, Vijayasarathi Upadhyayula, Zhongfa Liu, Shujun Liu, Jiuxia Pang et al. "Quantification of Intracellular Decitabine-Triphosphate with A Novel, Highly Sensitive and Specific LC-MS/MS Assay in Acute Myeloid Leukemia Patients Treated with Low Dose Decitabine." Blood 114, n.º 22 (20 de noviembre de 2009): 3782. http://dx.doi.org/10.1182/blood.v114.22.3782.3782.
Texto completoDeZern, Amy E., Amer M. Zeidan, John Barnard, Wesley Hand, Najla Al Ali, Francis Brown, Cassie Zimmerman et al. "Differential Response to Hypomethylating Agents Based on Sex: A Report on Behalf of the MDS Clinical Research Consortium (MDS CRC)". Blood 126, n.º 23 (3 de diciembre de 2015): 2889. http://dx.doi.org/10.1182/blood.v126.23.2889.2889.
Texto completoMa, Yunju, Changju Qu, Haiping Dai, Sining Liu, Qingya Cui, Wei Cui, Jia Yin et al. "Decitabine in Combination with Fludarabine and Cyclophosphamide As Lymphodepletion Regimen Followed By CD19/CD22 Bispecific Targeted CAR-T Therapy Significantly Improves Survival in Relapsed/Refractory B-ALL Patients: A Pilot Study". Blood 138, Supplement 1 (5 de noviembre de 2021): 1754. http://dx.doi.org/10.1182/blood-2021-152041.
Texto completoJabbour, Elias J., Nicholas J. Short, Xuelin Huang, Abhishek Maiti, Tapan M. Kadia, Naval Daver, Gautam Borthakur et al. "A Randomized Phase II Study of Low-Dose Decitabine Versus Azacitidine in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes: A Report on Behalf of the MDS Clinical Research Consortium". Blood 128, n.º 22 (2 de diciembre de 2016): 226. http://dx.doi.org/10.1182/blood.v128.22.226.226.
Texto completoBrady, Casper, Mark E. Davis y Bingjun Xu. "Integration of thermochemical water splitting with CO2 direct air capture". Proceedings of the National Academy of Sciences 116, n.º 50 (21 de noviembre de 2019): 25001–7. http://dx.doi.org/10.1073/pnas.1915951116.
Texto completoGillaspie, A. G. y S. A. Ghabrial. "First Report of Peanut Stunt Cucumovirus Naturally Infecting Desmodium sp". Plant Disease 82, n.º 12 (diciembre de 1998): 1402. http://dx.doi.org/10.1094/pdis.1998.82.12.1402a.
Texto completoLübbert, Michael, Hartmut Bertz, Björn H. Rüter, Roland H. Mertelsmann y Jürgen Finke. "Non-Intensive AML/MDS Treatment with Low-Dose Decitabine Prior to Reduced-Intensity Conditioning (RIC) and Allogeneic Blood Stem Cell Transplantation of Older Patients." Blood 108, n.º 11 (16 de noviembre de 2006): 5257. http://dx.doi.org/10.1182/blood.v108.11.5257.5257.
Texto completoSuino-Powell, Kelly, Yong Xu, Chenghai Zhang, Yong-guang Tao, W. David Tolbert, S. Stoney Simons y H. Eric Xu. "Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol". Molecular and Cellular Biology 28, n.º 6 (26 de diciembre de 2007): 1915–23. http://dx.doi.org/10.1128/mcb.01541-07.
Texto completoWilms, Anna Lena y Roman Seer. "Tax Transparency in the European Union Regarding Country by Country Reporting (BEPS Action 13)". EC Tax Review 25, Issue 5/6 (1 de noviembre de 2016): 325–34. http://dx.doi.org/10.54648/ecta2016032.
Texto completoIssa, J., H. M. Kantarjian y H. I. Saba. "Cytogenetic responses to the hypomethylating agent, decitabine (DAC), in a phase III trial of DAC vs supportive care (SC) in patients (pts) with myelodysplastic syndromes (MDS)". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 6501. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.6501.
Texto completoDuchmann, Matthieu, Thorsten Braun, Olivier Kosmider, Aline Renneville, Uwe Platzbecker, Lionel Ades, Marie Sebert et al. "A Two-Gene Classifier for Chronic Myelomonocytic Leukemia (CMML) Patients Treated with Hypomethylating Agents (HMA): A Report By the GFM". Blood 126, n.º 23 (3 de diciembre de 2015): 2872. http://dx.doi.org/10.1182/blood.v126.23.2872.2872.
Texto completoSmith, Alyssa D., Chunwan Lu, Daniela Payne, Amy V. Paschall, John David Klement, Priscilla S. Redd, Mohammed Ibrahim et al. "Autocrine IL6 activates the STAT3-DNMT axis to silence the TNFa-RIP1 necroptosis pathway to sustain myeloid-derived suppressor cell survival and accumulation". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 164.10. http://dx.doi.org/10.4049/jimmunol.204.supp.164.10.
Texto completoSurdu, D. "Multi-decade voltage dividers with phase regulation". Metrology and instruments, n.º 1 (25 de marzo de 2019): 14–20. http://dx.doi.org/10.33955/2307-2180(1)2019.14-20.
Texto completoHsieh, Wen-Pin, Yi-Chi Tsao y Chun-Hung Lin. "Thermal Conductivity of Helium and Argon at High Pressure and High Temperature". Materials 15, n.º 19 (26 de septiembre de 2022): 6681. http://dx.doi.org/10.3390/ma15196681.
Texto completoSega, Naonori, Yuta Somei, Hiroshi Shimada y Yoshinao Mizugaki. "Operation of a 4-bit RSFQ digital-to-analog converter based on a binary split-confluence configuration". Journal of Physics: Conference Series 2323, n.º 1 (1 de agosto de 2022): 012033. http://dx.doi.org/10.1088/1742-6596/2323/1/012033.
Texto completoYu, Cuiping, Weilong Wu, Min Gao y Yu Liu. "Modified Cellulose with BINAP-Supported Rh as an Efficient Heterogeneous Catalyst for Asymmetric Hydrogenation". Catalysts 12, n.º 1 (12 de enero de 2022): 83. http://dx.doi.org/10.3390/catal12010083.
Texto completoMajumder, S. y V. K. Baranwal. "First Report of Garlic common latent virus in Garlic from India". Plant Disease 93, n.º 1 (enero de 2009): 106. http://dx.doi.org/10.1094/pdis-93-1-0106c.
Texto completoEnglisch, Joachim y Nevia Cicin-Šain. "DAC 7: An Entire New Framework for Joint Audits in the EU: How Do the Taxpayers Fare?" Intertax 50, Issue 1 (1 de enero de 2022): 7–27. http://dx.doi.org/10.54648/taxi2022002.
Texto completoFeinberg, B. A., J. Gilmore, W. Hawke y T. Gondesen. "Changing the treatment paradigm for patients with MDS: How the development of therapeutics influences population-based care in community oncology, the Georgia Cancer Specialists Outcomes Database experience". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 7080. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.7080.
Texto completoPusic, Iskra, Jaebok Choi, Noel Bernabe, Camille N. Abboud, Peter Westervelt, Ravi Vij, Amanda F. Cashen, Geoffrey L. Uy, Keith E. Stockerl-Goldstein y John F. Dipersio. "Maintenance Therapy With Decitabine After Allogeneic Hematopoietic Stem Cell Transplantation For Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome". Blood 122, n.º 21 (15 de noviembre de 2013): 4638. http://dx.doi.org/10.1182/blood.v122.21.4638.4638.
Texto completoLübbert, Michael, Pierre W. Wijermans y Björn H. Rüter. "Re-Treatment with Low-Dose 5-Aza-2′-Deoxycytidine (Decitabine) Results in Second Remissions of Previously Responsive MDS Patients." Blood 104, n.º 11 (16 de noviembre de 2004): 1447. http://dx.doi.org/10.1182/blood.v104.11.1447.1447.
Texto completoHolowiecki, Jerzy, Sebastian Grosicki, Andrzej Hellmann, Aleksander Skotnicki, Tadeusz Robak, Wieslaw W. Jedrzejczak, Lech Konopka, Kazimierz Kuliczkowski, Slawomira Kyrcz-Krzemien y Beata Stella-Holowiecka. "Improved Survival in Acute Myeloid Leukaemia Patients Aged over 40 Given Cladribine in Combination with Standard Remission Induction (DA 3+7) and Consolidation Treatment (HD AraC). Seven Year Follow-Up of Prospective, Cooperative PALG Study." Blood 108, n.º 11 (1 de noviembre de 2006): 2003. http://dx.doi.org/10.1182/blood.v108.11.2003.2003.
Texto completoHolowiecki, Jerzy, Sebastian Grosicki, Tadeusz Robak, Slawomira Krzemien, Sebastian Giebel, Andrzej Hellmann, Aleksander Skotnicki et al. "Addition of Cladribine to the Standard AML Treatment Improves Long-Term Outcome in High Tumor Burden and Older Than 40 Years Acute Myeloid Leukemia Patients. Five-Year Follow-Up of the Polish Adult Leukemia Group (PALG 1999 DAC vs. DA Study)." Blood 104, n.º 11 (16 de noviembre de 2004): 1795. http://dx.doi.org/10.1182/blood.v104.11.1795.1795.
Texto completoSavona, Michael R., Olatoyosi Odenike, Philip C. Amrein, David P. Steensma, Wael A. Harb, Amy E. DeZern, Laura C. Michaelis et al. "Results of First in Human (FIH) Phase 1 Pharmacokinetic (PK) Guided Dose-Escalation Study of ASTX727, a Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine in Subjects with Myelodysplastic Syndromes (MDS)". Blood 126, n.º 23 (3 de diciembre de 2015): 1683. http://dx.doi.org/10.1182/blood.v126.23.1683.1683.
Texto completoCanuti, Marta, Joost T. P. Verhoeven, Hannah J. Munro, Sheena Roul, Davor Ojkic, Gregory J. Robertson, Hugh G. Whitney, Suzanne C. Dufour y Andrew S. Lang. "Investigating the Diversity and Host Range of Novel Parvoviruses from North American Ducks Using Epidemiology, Phylogenetics, Genome Structure, and Codon Usage Analysis". Viruses 13, n.º 2 (28 de enero de 2021): 193. http://dx.doi.org/10.3390/v13020193.
Texto completoAlmstedt, Maika, Dietmar Pfeifer y Michael Lubbert. "Cancer Testis Antigens Residing on the X-Chromosome Are Preferentially Derepressed in Myeloid Leukemic Cells by the DNA Demethylating Agent 5-Aza-2’-Deoxycytidine (DAC)." Blood 112, n.º 11 (16 de noviembre de 2008): 2247. http://dx.doi.org/10.1182/blood.v112.11.2247.2247.
Texto completoZeidan, Amer M., Maya Ridinger, Peter J. P. Croucher, Errin Samuëlsz, Mark Erlander, Katherine L. Ruffner y Eunice S. Wang. "Predictive Biomarkers of Response to the Polo-like Kinase 1 (PLK1) Inhibitor, Onvansertib, in Combination with Decitabine in Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)". Blood 138, Supplement 1 (5 de noviembre de 2021): 3431. http://dx.doi.org/10.1182/blood-2021-145129.
Texto completoInten Meutia. "Analysis of GRI Reporter". Think India 16, n.º 2 (15 de agosto de 2013): 40–54. http://dx.doi.org/10.26643/think-india.v16i2.7822.
Texto completoHolowiecki, Jerzy, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Janusz Kloczko, Kazimierz Sulek, Andrzej Hellmann, Aleksander Skotnicki et al. "Prospective, Randomized, Multicenter Phase III, Polish Adult Leukemia Group (PALG) Study Comparing DAF (DNR+AraC+Fludarabine), DAC (DNR+AraC+Cladribine), and Standard DA Regimen in Induction of Untreated Acute Myeloid Leukemia Patients - First Report." Blood 106, n.º 11 (16 de noviembre de 2005): 4616. http://dx.doi.org/10.1182/blood.v106.11.4616.4616.
Texto completoHofmeister, A. M. "Infrared Microspectroscopy in Earth and Planetary Science: Recent Developments, Including In Situ High-Pressure, High-Temperature Techniques". Microscopy and Microanalysis 3, S2 (agosto de 1997): 857–58. http://dx.doi.org/10.1017/s143192760001117x.
Texto completoWegscheider, W. "Report of the Study Group ”Quality Assurance and Accreditation" to the DAC-FECS". Accreditation and Quality Assurance 7, n.º 1 (1 de enero de 2002): 24. http://dx.doi.org/10.1007/s00769-001-0415-1.
Texto completoMouly, Enguerran, Emilie Rousseau, Cecile Planquette y Remi Delansorne. "Inecalcitol and Decitabine Synergize to Inhibit Cell Proliferation and to Induce Differentiation of Human Acute Myeloid Leukemia Cell Lines". Blood 132, Supplement 1 (29 de noviembre de 2018): 5234. http://dx.doi.org/10.1182/blood-2018-99-118125.
Texto completoClaus, Rainer, Dietmar Pfeifer, Maika Almstedt, Björn Hackanson, Manuela Zucknick, Christoph Plass y Michael Lübbert. "Decitabine (DAC) Treatment Induces Very Early In Vivo DNA Methylation and Transcriptome Changes in Primary AML Peripheral Blood Blasts". Blood 118, n.º 21 (18 de noviembre de 2011): 1360. http://dx.doi.org/10.1182/blood.v118.21.1360.1360.
Texto completoGarcia-Manero, Guillermo, Olatoyosi Odenike, Philip C. Amrein, David P. Steensma, Amy E. DeZern, Laura C. Michaelis, Stefan Faderl et al. "Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study". Blood 128, n.º 22 (2 de diciembre de 2016): 114. http://dx.doi.org/10.1182/blood.v128.22.114.114.
Texto completoXu, Xingguang, Matthew B. Myers, Friso G. Versteeg, Bobby Pejcic, Charles Heath y Colin D. Wood. "Direct air capture (DAC) of CO2 using polyethylenimine (PEI) “snow”: a scalable strategy". Chemical Communications 56, n.º 52 (2020): 7151–54. http://dx.doi.org/10.1039/d0cc02572k.
Texto completoBadar, Talha, Hagop M. Kantarjian, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Jorge E. Cortes, Naveen Pemmaraju, Sherry R. Pierce, Naval Daver y Srdan Verstovsek. "Therapeutic Benefit of Decitabine, a Hypomethylating Agent, in Patients with Myeloproliferative Neoplasm in Blastic Phase/Acute Myeloid Leukemia (MPN-AML), Accelerated Phase (MPN-AP), and DIPSS-Plus High Risk Primary Myelofibrosis (PMF)". Blood 124, n.º 21 (6 de diciembre de 2014): 3186. http://dx.doi.org/10.1182/blood.v124.21.3186.3186.
Texto completoKoemets, Egor, Liang Yuan, Elena Bykova, Konstantin Glazyrin, Eiji Ohtani y Leonid Dubrovinsky. "Interaction Between FeOOH and NaCl at Extreme Conditions: Synthesis of Novel Na2FeCl4OHx Compound". Minerals 10, n.º 1 (5 de enero de 2020): 51. http://dx.doi.org/10.3390/min10010051.
Texto completoFujita, Yoko, Linpeng Wei, Jonathan T. C. Liu y Nader Sanai. "SURG-04. INTRAOPERATIVE HAND-HELD LINE-SCANNED DUAL-AXIS CONFOCAL MICROSCOPY FOR VISUALIZING LOW-GRADE GLIOMAS". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi240. http://dx.doi.org/10.1093/neuonc/noz175.1005.
Texto completoSanna, Marco, Giovanni Caocci, Adriana Vacca, Eugenia Piras, Federica Orrù y Giorgio La Nasa. "Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation". Case Reports in Hematology 2013 (2013): 1–2. http://dx.doi.org/10.1155/2013/258028.
Texto completoHuang, Xiaomeng, Sebastian Schwind, Bo Yu, Jiuxia Pang, Ramasamy Santhanam, Kenneth K. Chan, Ramiro Garzon et al. "Targeted Delivery of MicroRNA-29b by Nanoparticles Provides Antileukemic Activity and Increases Sensitivity to the Hypomethylating Agent Decitabine (DAC) in Acute Myeloid Leukemia (AML)". Blood 118, n.º 21 (18 de noviembre de 2011): 81. http://dx.doi.org/10.1182/blood.v118.21.81.81.
Texto completoBlount, A. R., R. N. Pittman, B. A. Smith, R. N. Morgan, W. Dankers, R. K. Sprenkel y M. T. Momol. "First Report of Peanut stunt virus in Perennial Peanut in North Florida and Southern Georgia". Plant Disease 86, n.º 3 (marzo de 2002): 326. http://dx.doi.org/10.1094/pdis.2002.86.3.326c.
Texto completoKeane, Robert G. y Howard Fireman. "Producibility in the Naval Ship Design Process: A Progress Report". Journal of Ship Production 9, n.º 04 (1 de noviembre de 1993): 210–23. http://dx.doi.org/10.5957/jsp.1993.9.4.210.
Texto completoOhanian, Maro, Tara L. Lin, Ellen Ritchie, Michael Craig, Apurv Agrawal, Kathleen G. Halka, Naveen Pemmaraju et al. "Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with High-Risk and Relapsed/Refractory Acute Myeloid Leukemia (AML)". Blood 138, Supplement 1 (5 de noviembre de 2021): 1281. http://dx.doi.org/10.1182/blood-2021-152750.
Texto completo